1. Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review
- Author
-
Nga Lei Tam, Linwei Wu, Yuchen Hou, Bing Liao, Xiaoshun He, Shun-Jun Fu, Jie Yang, Xuzhi Zhang, Zhicheng Xue, and Yi Ma
- Subjects
Graft Rejection ,Male ,Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,Occlusive disease ,Hepatic Veno-Occlusive Disease ,Connective tissue ,complication ,Liver transplantation ,Hepatic Veins ,digestive system ,Tacrolimus ,03 medical and health sciences ,0302 clinical medicine ,Liver Cirrhosis, Alcoholic ,Fibrous obliteration ,medicine ,Humans ,HVOD ,Clinical Case Report ,Vein ,liver transplantation ,business.industry ,Centrilobular necrosis ,Ultrasonography, Doppler ,General Medicine ,Middle Aged ,digestive system diseases ,medicine.anatomical_structure ,surgical procedures, operative ,Liver ,030220 oncology & carcinogenesis ,alcoholic liver cirrhosis ,030211 gastroenterology & hepatology ,Complication ,business ,Tomography, X-Ray Computed ,Immunosuppressive Agents ,Research Article - Abstract
Rationale: Hepatic vein occlusive disease (HVOD) is a rare complication after liver transplantation, which is characterized by nonthrombotic, fibrous obliteration of the small centrilobular hepatic veins by connective tissue and centrilobular necrosis in zone 3 of the acini. HVOD after solid organ transplantation has been reported; recently, most of these reports with limited cases have documented that acute cell rejection and immunosuppressive agents are the major causative factors. HVOD is relatively a rare complication of liver transplantation with the incidence of approximately 2%. Patient concerns: A 59-year-old male patient with alcoholic liver cirrhosis underwent liver transplantation in our center. He suffered ascites, renal impairment 3 months after the surgery while liver enzymes were in normal range. Diagnoses: Imagining and pathology showed no evidence of rejection or vessels complications. HVOD was diagnosed with pathology biopsy. Interventions: Tacrolimus was withdrawn and the progression of HVOD was reversed. Outcomes: Now, this patient has been followed up for 6 months after discharge with normal liver graft function. Lessons: The use of tacrolimus in patients after liver transplantation may cause HVOD. Patients with jaundice, body weight gain, and refractory ascites should be strongly suspected of tacrolimus related HVOD.
- Published
- 2018